Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-162.82%
operating margin TTM
-168.69%
revenue TTM
6.71 Million
revenue per share TTM
0.63$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | 0.00 |
| price to book ratio | 0.00 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -0.00 |
| price fair value | 0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -168.69% |
| pretax profit margin | -0.0% |
| net profit margin | -162.82% |
| return on assets | -48.73% |
| return on equity | -231.3% |
| return on capital employed | -59.91% |
liquidity ratio | |
|---|---|
| current ratio | 6.36 |
| quick ratio | 6.36 |
| cash ratio | 0.00 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 129.96 |
| days of payables outstanding | 75.55 |
| cash conversion cycle | 54.40 |
| receivables turnover | 2.81 |
| payables turnover | 4.83 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -25,441,916.66 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1,214,930.12 |
| cash per share | 2,137,193.50 |
| operating cash flow per share | -1,214,930.12 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Marker Therapeutics, Inc. (NASDAQ:MRKR) reported earnings?
Marker Therapeutics, Inc. (MRKR) published its most recent earnings results on 14-11-2024.
What is Marker Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Marker Therapeutics, Inc. (NASDAQ:MRKR)'s trailing twelve months ROE is -231.3%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Marker Therapeutics, Inc. (MRKR) currently has a ROA of -48.73%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MRKR's net profit margin stand at?
MRKR reported a profit margin of -162.82% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MRKR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.36 in the most recent quarter. The quick ratio stood at 6.36, with a Debt/Eq ratio of 0.00.